日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236

RRAS 和 RRAS2 突变是肺癌中常见的致癌驱动因素,并且对泛 RAS 抑制剂 RMC-6236 敏感。

Pfeil, Alexander J; Zhang, Tom; Cheng, Ryan; Mattar, Marissa S; Gomez Marti, Juan Luis; Gili, Leo; Lai, Rachel; Khodos, Inna; Master, Rohan P; Dix, Jenna-Marie; Gazzo, Andrea; Arbour, Kathryn C; de Stanchina, Elisa; Febres-Aldana, Christopher A; Ladanyi, Marc; Yang, Soo-Ryum; Somwar, Romel

Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

对致癌MET融合基因的泛癌分析揭示了对MET靶向治疗具有不同敏感性的不同致病基因组亚群

Febres-Aldana Christopher A, Vojnic Morana, Odintsov Igor, Zhang Tom, Cheng Ryan, Beach Catherine Z, Lu Daniel, Mattar Marissa S, Gazzo Andrea M, Gili Leo, Harshan Manju, Ameri Ali, Machnicki Stephen, Xiao Xiuying, Lockwood William W, Zhou Xiao-Yan, Yao Qianlan, Drilon Alexander, Rekhtman Natasha, Shah Nameeta, Li Anqi, Liu Zebing, Yang Soo-Ryum, Davare Monika A, Ladanyi Marc, Somwar Romel

RRAS and RRAS2 mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236

RRAS 和 RRAS2 突变是肺癌中常见的致癌驱动因素,并且对泛 RAS 抑制剂 RMC-6236 敏感。

Pfeil, Alexander J; Zhang, Tom; Cheng, Ryan; Mattar, Marissa S; Gomez Marti, Juan Luis; Gili, Leo; Lai, Rachel; Khodos, Inna; Master, Rohan P; Dix, Jenna-Marie; Gazzo, Andrea; Arbour, Kathryn C; de Stanchina, Elisa; Febres-Aldana, Christopher A; Ladanyi, Marc; Yang, Soo-Ryum; Somwar, Romel

HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor

HER2抗体-药物偶联物对促纤维增生性小圆细胞肿瘤有效

Zhang, Tom; Febres-Aldana, Christopher A; Liu, Zebing; Dix, Jenna-Marie; Cheng, Ryan; Dematteo, Raymond G; Lui, Allan J W; Khodos, Inna; Gili, Leo; Mattar, Marissa S; Lisanti, Jeanine; Kwong, Charlene; Linkov, Irina; Tipping, Murray J; de Stanchina, Elisa; Odintsov, Igor; Ladanyi, Marc; Somwar, Romel